Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Bordoni

Showing results (91-100 of 101) with videos related to

Pageof 11
Sort By:
Anticancer Research|August 10, 2002
Ten-year survival results in metastatic renal cell cancer patients treated with monoimmunotherapy with subcutaneous low-dose interleukin-2P Lissoni, V Bordin, M Vaghi, et al.
European Journal of Cancer Care|February 10, 2016
Days spent in acute care hospitals at the end of life of cancer patients in four Swiss cantons: a retrospective database study (SAKK 89/09)K W Matter-Walstra, R Achermann, R Rapold, et al.
Journal of Inherited Metabolic Disease|April 10, 2009
Neuropathological study of skeletal muscle, heart, liver, and brain in a neonatal form of glycogen storage disease type IV associated with a new mutation in GBE1 geneC Lamperti, S Salani, S Lucchiari, et al.
Annals of Neurology|February 5, 1998
Cytochrome c oxidase subunit I microdeletion in a patient with motor neuron diseaseG P Comi, A Bordoni, S Salani, et al.
Neurology|October 22, 1998
Partial depletion and multiple deletions of muscle mtDNA in familial MNGIE syndromeA Papadimitriou, G P Comi, G M Hadjigeorgiou, et al.
Neuromuscular Disorders : NMD|March 3, 2015
Adult polyglucosan body disease: clinical and histological heterogeneity of a large Italian familyI Colombo, S Pagliarani, S Testolin, et al.
Urologia Internationalis|April 27, 2000
Five-year survival results of subcutaneous low-dose immunotherapy with interleukin-2 alone in metastatic renal cell cancer patientsV Bordin, L Giani, S Meregalli, et al.
European Journal of Cancer (Oxford, England : 1990)|January 8, 2014
Completeness and timeliness: Cancer registries could/should improve their performanceR Zanetti, I Schmidtmann, L Sacchetto, et al.
British Journal of Cancer|July 1, 2010
Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort StudyS Franceschi, M Lise, G M Clifford, et al.
Journal of Neurology|October 13, 2001
Retrospective study of a large population of patients affected with mitochondrial disorders: clinical, morphological and molecular genetic evaluationM Sciacco, A Prelle, G P Comi, et al.
Pageof 11

Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
Anticancer Research|August 10, 2002
Ten-year survival results in metastatic renal cell cancer patients treated with monoimmunotherapy with subcutaneous low-dose interleukin-2P Lissoni, V Bordin, M Vaghi, et al.
European Journal of Cancer Care|February 10, 2016
Days spent in acute care hospitals at the end of life of cancer patients in four Swiss cantons: a retrospective database study (SAKK 89/09)K W Matter-Walstra, R Achermann, R Rapold, et al.
Journal of Inherited Metabolic Disease|April 10, 2009
Neuropathological study of skeletal muscle, heart, liver, and brain in a neonatal form of glycogen storage disease type IV associated with a new mutation in GBE1 geneC Lamperti, S Salani, S Lucchiari, et al.
Annals of Neurology|February 5, 1998
Cytochrome c oxidase subunit I microdeletion in a patient with motor neuron diseaseG P Comi, A Bordoni, S Salani, et al.
Neurology|October 22, 1998
Partial depletion and multiple deletions of muscle mtDNA in familial MNGIE syndromeA Papadimitriou, G P Comi, G M Hadjigeorgiou, et al.
Neuromuscular Disorders : NMD|March 3, 2015
Adult polyglucosan body disease: clinical and histological heterogeneity of a large Italian familyI Colombo, S Pagliarani, S Testolin, et al.
Urologia Internationalis|April 27, 2000
Five-year survival results of subcutaneous low-dose immunotherapy with interleukin-2 alone in metastatic renal cell cancer patientsV Bordin, L Giani, S Meregalli, et al.
European Journal of Cancer (Oxford, England : 1990)|January 8, 2014
Completeness and timeliness: Cancer registries could/should improve their performanceR Zanetti, I Schmidtmann, L Sacchetto, et al.
British Journal of Cancer|July 1, 2010
Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort StudyS Franceschi, M Lise, G M Clifford, et al.
Journal of Neurology|October 13, 2001
Retrospective study of a large population of patients affected with mitochondrial disorders: clinical, morphological and molecular genetic evaluationM Sciacco, A Prelle, G P Comi, et al.
Pageof 11